Position in LNTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,434,343
+$2,138,871 QoQ
Shares Held
216,669
+0.9% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FIL Ltd holds $820,100,378 across 8 Drug Manufacturers - Specialty & Generic names. LNTH ranks #4 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,487,134 | $648,634,110 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,694,634 | $111,282,375 | |
| 3 | VTRS |
Viatris Inc
|
2,886,622 | $38,998,263 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
This page
|
216,669 | $16,434,343 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
84,619 | $2,024,932 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,021 | $1,791,392 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
6,752 | $889,508 | |
| 8 | HLN |
Haleon plc
|
4,541 | $45,455 |
All Filings in LNTH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,434,343 | 216,669 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,295,472 | 214,808 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||